- All Products
- / Analytical Science
- / Drug Impurity Reference Substance
- / Anti-Tumor Drugs
- / Everolimus impurity
Everolimus impurity
Download Everolimus impurity Related Products
Everolimus (RAD001) is a derivative of rapamycin (HY-10219) and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to produce an immunosuppressive complex. Everolimus inhibits tumor cell proliferation and induces apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities. ChemScene offers a range of Everolimus impurities to meet customer application requirements.
Everolimus impurity
download
Related products
In-stock：
Functional group：
Monofunctional group
Bifunctional group
Trifunctional group
Skeleton：
Inventory Status：
Chirality：
Purity：
Rule of 5：
-
In-stockPurity: ≥98%
Cat. No. : CS-0459965 -
In-stockPurity: ≥98%
Cat. No. : CS-0164109 -
In-stockPurity: ≥98%
Cat. No. : CS-0164112 -
In-stockPurity: ≥98%
Cat. No. : CS-0164113CAS No. : 745779-75-3* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0459874CAS No. :* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0459875 -
In-stockPurity: ≥98%
Cat. No. : CS-0459879CAS No. :* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0459881 -
In-stockPurity: ≥98%
Cat. No. : CS-0459883CAS No. :* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0459884CAS No. : 2607-52-5* This product is not sold in the region.